Entero Healthcare Solutions

1,232.80
+15.60
(1.28%)
Market Cap
5,363.80 Cr
EPS
21.80
PE Ratio
56.61
Dividend Yield
0.00 %
Industry
Retail
52 Week High
1,584.25
52 Week Low
1,064.00
PB Ratio
3.11
Debt to Equity
0.35
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+66.67 %
+66.67 %
Hold
Hold+33.33 %
+33.33 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
869.30
#1 10,405.00
69.26
#1 6,136.05
#1 23.05
#1 135
#1 52.68
43.92
1,232.80
#2 5,363.80
#1 56.61
#2 5,095.78
#2 19.09
#2 113
#2 48.11
56.72
41.65
100.30
-
9.20
-4.17
-2
-166.67
89.41

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
19.09 %
Net Income Growth
-458.56 %
Cash Flow Change
19.22 %
ROE
-230.11 %
ROCE
-12.10 %
EBITDA Margin (Avg.)
52.86 %

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
749
836
1,126
1,309
2,345
2,703
Fixed Assets
186
189
262
268
289
136
Current Assets
552
636
851
1,023
2,011
2,076
Capital Work in Progress
2
2
1
0
0
0
Investments
0
0
0
0
0
660
Other Assets
561
645
863
1,041
2,056
0
Total Liabilities
749
836
1,126
1,309
2,345
2,703
Current Liabilities
269
291
462
624
602
845
Non Current Liabilities
56
58
101
87
102
87
Total Equity
424
487
563
598
1,641
1,724
Reserve & Surplus
-16
-32
-62
-73
1,593
1,681
Share Capital
439
517
4
4
44
44

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
-23
-11
14
-21
122
Investing Activities
-203
-31
-162
-49
-704
Operating Activities
-37
-69
-35
-45
-37
Financing Activities
217
89
211
73
863

Share Holding

% Holding
Sept 2023
Feb 2024
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
78.85 %
52.44 %
52.44 %
52.44 %
52.44 %
52.44 %
52.42 %
FIIs
0.00 %
0.00 %
23.30 %
23.32 %
23.82 %
22.21 %
19.92 %
DIIs
0.00 %
1.36 %
2.28 %
2.06 %
7.73 %
8.77 %
9.64 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
5.72 %
4.95 %
5.00 %
4.06 %
4.36 %
5.41 %
Others
21.15 %
40.48 %
17.03 %
17.18 %
11.95 %
12.23 %
12.61 %
No of Share Holders
51
58
80,864
66,400
36,767
33,172
33,159

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
18 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
18 Sept 2025 1,140.05 1,233.50
27 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 May 2025 1,404.25 1,465.15
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 1,456.95 1,302.65
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 1,453.60 1,451.95
28 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Aug 2024 1,213.75 1,311.70

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
Closure of Trading Window10 days ago
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Jun 18, 2025
Intimation For Grant Of 5900 Options Pursuant To Entero Employee Stock Option Plan 2023 To The Eligible Employees Of The Company. Jun 18, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On June 18 2025Jun 18, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 04, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 28, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 27, 2025
Change In Designation Of Mr. Kevin Daftary From Non Executive Non Independent Director To Nominee DirectorMay 27, 2025
Appointment Of M/S. BNP & Associates Practicing Company Secretaries (Firm Registration No. P2014MH037400) As The Secretarial Auditor Of The CompanyMay 27, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 27, 2025
Announcement under Regulation 30 (LODR)-AcquisitionMay 27, 2025
Announcement Under Regulation 30 (LODR) - Change In Authorization Of Key Managerial Personnel ("KMP") For Determining Materiality Of An Event Or InformationMay 27, 2025
Results - Audited Financial Results For Quarter And Year Ended March 31 2025.May 27, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On May 27 2025May 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
Update- Submission Of Resignation Letter Of DirectorMay 22, 2025
Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended March 31 2025.May 21, 2025
Submission Of Monitoring Agency Report For The Quarter Ended March 31 2025May 09, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 28, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 28, 2025
Closure of Trading WindowMar 24, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 21, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On March 21 2025Mar 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 19, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 20, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 19, 2025
Intimation Of Cancellation Of Analyst/ Institutional Investor Meeting Scheduled On February 21 2025Feb 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 12, 2025
Statement Of Deviation For The Quarter Ended December 31 2024Feb 12, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 12, 2025
Integrated Filing (Financial)Feb 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On February 12 2025Feb 12, 2025
Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 08, 2025
Board Meeting Intimation for Approval And Take On Record The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter And Nine-Months Ended December 31 2024.Feb 03, 2025
Intimation Regarding Receipt Of Listing And Trading Approval For 13940 Equity Shares From The BSE Limited (BSE) And National Stock Exchange Of India Limited (NSE)Jan 31, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 25, 2025
Disclosure under Regulation 30A of LODRJan 16, 2025

Technical Indicators

RSI(14)
Neutral
56.72
ATR(14)
Less Volatile
42.80
STOCH(9,6)
Neutral
71.72
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
15.80
ADX(14)
Strong Trend
30.57
UO(9)
Bearish
54.95
ROC(12)
Uptrend And Accelerating
8.01
WillR(14)
Overbought
-9.74